Literature DB >> 9724682

Bone mineral density in children with myelomeningocele.

A Quan1, R Adams, E Ekmark, M Baum.   

Abstract

BACKGROUND: Difficulties with ambulation in patients with myelomeningocele often lead to physical inactivity, osteoporosis, and subsequent development of pathologic fractures.
OBJECTIVE: The purpose of this study was to examine bone mineral density and biochemical markers of bone metabolism in patients with myelomeningocele. DESIGN AND METHODS: A total of 35 patients between 6 and 19 years of age with myelomeningocele (ambulatory and nonambulatory) were randomly chosen at the Texas Scottish Rite Hospital for Children. We measured bone mineral density of the distal radius in these patients using single photon absorptiometry and measured the biochemical markers of bone metabolism including parathyroid hormone, 1,25 vitamin D, osteocalcin, urinary pyridinolines/deoxypyridinolines, and urinary calcium excretion.
RESULTS: Bone mineral density of the distal radius in the patients with myelomeningocele was approximately 1 to 2 standard deviation units below the mean of the normal population. There were no significant differences between ambulators and nonambulators. However, bone mineral density of the 8 patients who suffered multiple fractures (19) was significantly lower than that for those remaining patients without fractures. Elevated urinary pyridinoline levels, which indicate elevated bone reabsorption, were found more frequently in both non- and limited ambulators than in full-time ambulators. Urinary calcium excretion also was greater than twofold higher in nonambulatory patients versus ambulatory patients. There were no other differences in the biochemical markers of bone metabolism (osteocalcin, parathyroid hormone, 1,25 vitamin D, and urinary deoxypyridinolines) between ambulators and nonambulators. Bone mineral density rises in normal growing children 6 to 19 years of age. When the boys and girls were considered separately, bone mineral density rises with age in boys, but not in girls.
CONCLUSION: Patients with myelomeningocele have decreased bone mineral density and are at risk of suffering pathologic bone fractures. The measurement of bone mineral density may help to identify those patients at greatest risk of suffering multiple fractures. The urinary calcium excretion of nonambulators was higher than that of ambulators and likely contributes to their decreased bone mineral density. Bone mineral density increases with age in boys, but not in girls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724682     DOI: 10.1542/peds.102.3.e34

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Children with spina bifida are at risk for low bone density.

Authors:  Elizabeth A Szalay; Asad Cheema
Journal:  Clin Orthop Relat Res       Date:  2011-05       Impact factor: 4.176

2.  An approach for determining quantitative measures for bone volume and bone mass in the pediatric spina bifida population.

Authors:  Rachel E Horenstein; Sandra J Shefelbine; Nicole M Mueske; Carissa L Fisher; Tishya A L Wren
Journal:  Clin Biomech (Bristol, Avon)       Date:  2015-04-23       Impact factor: 2.063

3.  Bone mineral density in pediatric patients with meningomyelocele.

Authors:  Ihsan Kafadar; Betul Aydin Kilic; Figen Koymen Yilmaz; Mustafa Kilic
Journal:  Childs Nerv Syst       Date:  2016-01       Impact factor: 1.475

4.  Fixation of subtrochanteric extending/derotational femoral osteotomies with the Locking Compression Plate in ambulatory neuro-orthopaedic patients.

Authors:  Mathias Haefeli; Hanspeter Huber; Stefan Dierauer; Leonhard E Ramseier
Journal:  J Child Orthop       Date:  2010-08-01       Impact factor: 1.548

5.  Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida.

Authors:  Nienke P Dosa; Michael Eckrich; Danielle A Katz; Margaret Turk; Gregory S Liptak
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

6.  Fractures in myelomeningocele.

Authors:  Michael Akbar; Bjoern Bresch; Patric Raiss; Carl Hans Fürstenberg; Thomas Bruckner; Thorsten Seyler; Claus Carstens; Rainer Abel
Journal:  J Orthop Traumatol       Date:  2010-08-19

7.  Bone mineral density in children with myelomeningocele: effect of hydrochlorothiazide.

Authors:  Albert Quan; Richard Adams; Elaine Ekmark; Michel Baum
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

8.  Evaluation of bone mineral density after ileocystoplasty in children with and without myelomeningocele.

Authors:  Ugur Boylu; Kaya Horasanli; Orhan Tanriverdi; Muammer Kendirci; Eyup Gumus; Cengiz Miroglu
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

Review 9.  Osteoporosis in paediatric patients with spina bifida.

Authors:  Humberto Marreiros; Humberto Filipe Marreiros; Clara Loff; Eulalia Calado
Journal:  J Spinal Cord Med       Date:  2012-01       Impact factor: 1.985

10.  Fasting serum blood measures of bone and lipid metabolism in children with myelomeningocele for early detection of cardiovascular and bone fragility risk factors.

Authors:  Alexander Van Speybroeck; Nicole M Mueske; Steven D Mittelman; Richard K Kremer; Deirdre D Ryan; Tishya A L Wren
Journal:  J Spinal Cord Med       Date:  2015-12-14       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.